| Dr Douglas J Grunwald, MD | |
|
2200 Whitney Ave Ste 360, Hamden, CT 06518-3602 | |
| (203) 281-4463 | |
| (203) 287-2930 |
| Full Name | Dr Douglas J Grunwald |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 2200 Whitney Ave Ste 360, Hamden, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154616001 | NPI | - | NPPES |
| 1154616001 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 56120 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hhc Physician Services Pllc | 9537573357 | 94 |
News Archive
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.
Researchers at the University of Sheffield have shown that mothers are choosing to have fewer children in order to give their children the best start in life, but by doing so are going against millenia of human evolution.
A survey conducted on 1,500 young Brits in the age group of 18 to 30 years felt that they could improve their job prospects by emigrating on a temporary basis. The most popular destinations were Australia, US and Canada. Also popular were destinations New Zealand and Spain.
Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced today that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.
› Verified 9 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.
Researchers at the University of Sheffield have shown that mothers are choosing to have fewer children in order to give their children the best start in life, but by doing so are going against millenia of human evolution.
A survey conducted on 1,500 young Brits in the age group of 18 to 30 years felt that they could improve their job prospects by emigrating on a temporary basis. The most popular destinations were Australia, US and Canada. Also popular were destinations New Zealand and Spain.
Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced today that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.
› Verified 9 days ago
| Entity Name | Hhc Physician Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669075610 PECOS PAC ID: 9537573357 Enrollment ID: O20210205000922 |
News Archive
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.
Researchers at the University of Sheffield have shown that mothers are choosing to have fewer children in order to give their children the best start in life, but by doing so are going against millenia of human evolution.
A survey conducted on 1,500 young Brits in the age group of 18 to 30 years felt that they could improve their job prospects by emigrating on a temporary basis. The most popular destinations were Australia, US and Canada. Also popular were destinations New Zealand and Spain.
Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced today that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas J Grunwald, MD 2200 Whitney Ave Ste 360, Hamden, CT 06518-3602 Ph: (203) 281-4463 | Dr Douglas J Grunwald, MD 2200 Whitney Ave Ste 360, Hamden, CT 06518-3602 Ph: (203) 281-4463 |
News Archive
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.
Researchers at the University of Sheffield have shown that mothers are choosing to have fewer children in order to give their children the best start in life, but by doing so are going against millenia of human evolution.
A survey conducted on 1,500 young Brits in the age group of 18 to 30 years felt that they could improve their job prospects by emigrating on a temporary basis. The most popular destinations were Australia, US and Canada. Also popular were destinations New Zealand and Spain.
Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced today that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.
› Verified 9 days ago
Ricardo F Cordido, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2200 Whitney Ave, Suite 180, Hamden, CT 06518 Phone: 203-407-2500 Fax: 203-407-5812 | |
Jennifer Su Thompson, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2200 Whitney Ave, Suite 360, Hamden, CT 06518 Phone: 203-281-4463 | |
Mr. Marian E Vulpe, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2200 Whitney Ave, Ste 180, Hamden, CT 06518 Phone: 203-407-2500 Fax: 203-407-5812 | |
Dr. Leonard E Grauer, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1952 Whitney Ave, Hamden, CT 06517 Phone: 203-773-3055 Fax: 203-281-5796 | |
Dr. Louis A. Telesford, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 2337 Whitney Ave, Hamden, CT 06518 Phone: 203-248-8142 Fax: 203-248-7764 | |
Dr. Stephen E Possick, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9 Washington Ave, Hamden, CT 06518 Phone: 203-281-6881 Fax: 203-287-9904 | |
Dr. Prem George Thomas, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 75 Augur St, Hamden, CT 06517 Phone: 203-776-2012 |